SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 25.08 |
| Enterprise Value ($M) | 21.12 |
| Book Value ($M) | 10.89 |
| Book Value / Share | 0.81 |
| Price / Book | 2.30 |
| NCAV ($M) | 10.76 |
| NCAV / Share | 0.80 |
| Price / NCAV | 2.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.97 |
| Return on Assets (ROA) | -0.70 |
| Return on Equity (ROE) | -1.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.66 |
| Current Ratio | 5.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25.22 |
| Assets | 25.35 |
| Liabilities | 14.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -24.20 |
| Net Income | -13.70 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -21.15 |
| Cash from Investing | -4.42 |
| Cash from Financing | 27.97 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Stonepine Capital Management, LLC | 4.60 | -15.24 | |
| 13G | Alafi Capital Co Llc | 9.60 | ||
| 13G/A | Aisling Capital V, LP | 3.90 | -25.00 | |
| 13G/A | Leerink Revelation Healthcare Fund I, L.p. | 0.00 | -100.00 | |
| 13D | Sanderling Venture Partners VI LP | 18.30 | ||
| 13G/A | Soleus Private Equity Fund III, L.P. | 8.50 | ||
| 13G/A | Lytton Laurence W | 4.40 | -37.99 | |
| 13D/A | Valence Investments SPV VI, LLC | 9.00 | 4.67 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,886 | 17,823 | 27.41 | |
| 5,063 | 21,303 | 23.77 | |
| 5,942 | 19,325 | 30.75 | |
| 13,333 | 37,363 | 35.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BTAI – BioXcel Therapeutics, Inc. | BULL – Webull Corporation |
| BYSI – BeyondSpring Inc. | CAPR – Capricor Therapeutics, Inc. |
| CASI – CASI Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io